Pharmacokinetics One- compartment Open Model Lec:2

Similar documents
One-Compartment Open Model: Intravenous Bolus Administration:

C OBJECTIVES. Basic Pharmacokinetics LESSON. After completing Lesson 2, you should be able to:

Chapter 4: One Compartment Open Model: Intravenous Bolus Administration

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

1. If the MTC is 100 ng/ml and the MEC is 0.12 ng/ml, which of the following dosing regimen(s) are in the therapeutic window?

General Principles of Pharmacology and Toxicology

PHA Final Exam Fall 2006

Basic Concepts of TDM

Applied Biopharmaceutics & Pharmacokinetics Sixth Edition

BIOPHARMACEUTICS and CLINICAL PHARMACY

UNIVERSITY OF THE WEST INDIES, ST AUGUSTINE

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

Biopharmaceutics. Lec: 4

Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment

Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHARMACOKINETICS SMALL GROUP I:

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE

Lippincott Questions Pharmacology

Biopharmaceutics Lecture-11 & 12. Pharmacokinetics of oral absorption

Determination of bioavailability

Basic pharmacokinetics. Frédérique Servin APHP hôpital Bichat Paris, FRANCE

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy

BASIC PHARMACOKINETICS

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA5128 Dose Optimization II Case Study I Spring 2013

Renal Function. 1. Glomerular filtration 2. Active tubular secretion 3. Passive tubular reabsorption 4. Excretion

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Drug dosing in Extremes of Weight

WHY... 8/21/2013 LEARNING OUTCOMES PHARMACOKINETICS I. A Absorption. D Distribution DEFINITION ADME AND THERAPEUIC ACTION

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Pharmacokinetics Overview

Adjusting phenytoin dosage in complex patients: how to win friends and influence patient outcomes

PHA First Exam Fall 2003

PHARMACOKINETICS OF DRUG ABSORPTION

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

It the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues.

Click to edit Master title style

The general Concepts of Pharmacokinetics

Case Study 2 Answers Spring 2006

Multiple IV Bolus Dose Administration

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Pharmacokinetics of drug infusions

PHA First Exam. Fall 2004

PHAR 7632 Chapter 16

Rational Dose Prediction. Pharmacology. φαρμακον. What does this mean? pharmakon. Medicine Poison Magic Spell

Prediction of THC Plasma and Brain Concentrations following. Marijuana Administration: Approach and Challenges

Volume of Distribution. Objectives. Volume of Distribution

DEFINITIONS. Pharmacokinetics. Pharmacodynamics. The process by which a drug is absorbed, distributed, metabolized and eliminated by the body

Section 5.2: Pharmacokinetic properties

Slide 1. Slide 2. Slide 3. Drug Action and Handling. Lesson 2.1. Lesson 2.1. Drug Action and Handling. Drug Action and Handling.

INTRODUCTION TO PHARMACOKINETICS

Osnove farmakokinetike. Aleš Mrhar. Prirejeno po. A First Course in Pharmacokinetics and Biopharmaceutics by David Bourne,

Intrasubject Variation in Elimination Half-Lives of Drugs Which Are Appreciably Metabolized

A primer on pharmacology

TDM of Aminoglycoside Antibiotics

PHA Final Exam Fall 2001

Research Article EVALUATION OF THE APPROPRIATENESS OF DRUG DOSAGE IN RENAL IMPAIRED PATIENTS IN A TERTIARY CARE HOSPITAL

Pharmacokinetics: The Basics

Pharmacotherapy Issues in the Pediatric Population

Principles of Pharmacokinetics

PHA Spring First Exam. 8 Aminoglycosides (5 points)

Nonlinear Pharmacokinetics

Received: ; Revised; Accepted: A REVIEW ON BIOAVAILABILITY AND BIOEQUIVALENCE STUDY Shashi Kant*, Bharat Parashar

PHAR 7633 Chapter 20 Non Compartmental Analysis

Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics

Assem Al Refaei. Sameer Emeish. Dr.Alia. Hodaifa Ababneh & Abdullah Shurafa

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University

DRUG DISTRIBUTION. Distribution Blood Brain Barrier Protein Binding

Pharmacokinetic Modeling & Simulation in Discovery and non-clinical Development

COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program September 23, 2010

The Influence of Physicochemical Properties on ADME

1 Introduction: The Why and How of Drug Bioavailability Research

Introduction to Pharmacokinetics

Chapter 12 DRUG THERAPY 2001 Dennis A. Noe

Name: UFID: PHA Exam 2. Spring 2013

Valproate overdose: what is the role of carnitine?

PHA 5128 Spring 2009 First Exam (Version B)

Pharmacokinetic-Pharmacodynamic Modeling of the D 2 and 5-HT 2A Receptor Occupancy of Risperidone and Paliperidone in Rats

Pharmacokinetics Applied to the Treatment of Asthma

Pharmacokinetics I. Dr. M.Mothilal Assistant professor

TDM Lecture 7 5 th Stage. TDM of Digoxin. Uses: Digoxin is usually used in heart failure associated and atrial fibrillation.

PHA 4120 Second Exam Key Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Pharmacodynamics & Pharmacokinetics 1

Renal Clearance. Dr. Eman El Eter

PHA Case Studies V (Answers)

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

Define the terms biopharmaceutics and bioavailability.

Pharmacokinetic Calculations

The importance of clearance

Understand the physiological determinants of extent and rate of absorption

Tala Saleh. Abdul Aziz ALShamali. Abdul Aziz ALShamali

Volume 1(3) May-June 2013 Page 351

Basic Concepts in Pharmacokinetics. Leon Aarons Manchester Pharmacy School University of Manchester

Use of Pediatric and Adult Midazolam Population Pharmacokinetics to Assess IM Dosing and Early Drug Exposure for Status Epilepticus

Mechanisms of Drug Action

Drug elimination and Hepatic clearance Chapter 6

Pharmacokinetics of ibuprofen in man. I. Free and total

Transcription:

22 Pharmacokinetics One- compartment Open Model Lec:2 Ali Y Ali BSc Pharmacy MSc Industrial Pharmaceutical Sciences Dept. of Pharmaceutics School of Pharmacy University of Sulaimani 1

Outline Introduction Drug disposition Volume of distribution Elimination rate constant Equations of one compartment models Significance of volume of distribution Clearance Ways of expression of Elimination Examples 2

Compartment models For understanding the drug disposition in the body, pharmacokinetic (PK) models are used. The model must account for: 1. Route of administration 2. Kinetic behaviour of the drug in the body 3

Mammillary Models 1. One- compartment open model Ka: absorption rate constant K: elimination rate constant 2. Multi- compartment open model (Shargel, Wu- Pong et al. 2007) 4

One- compartment Open Model Simplest model to describe drug distribution and elimination of drugs. This model assumes that the drug can enter or leave the body open the body (tank) acts like a single, uniform compartment. 5

Distribution Drug Disposition In the body such that the drug is injected all at once into a box (compartment) and that the drug distributes instantaneously and homogenously. Drug elimination occurs from the compartment immediately after injection (Shargel, Wu- Pong et al. 2007) 6

Route of Administration Simplest in terms of Use? Simplest from PK perspectives? Oral IV Bolus VS 7

IV bolus The entire dose of drug enters the bloodstream The drug absorption process is considered to be instantaneous. The drug distributes via the circulatory system to potentially all the tissues in the body. 8

Drug Uptake Uptake of drugs by various tissue organs will occur at varying rates, depending on Physiological factors :the blood flow to the tissue Drug factors : a) the lipophilicity of the drug b) the molecular weight of the drug c) the binding affinity of the drug for the tissue mass. 9

Elimination Most drugs are eliminated from the body either through 1. Kidney and/or 2. Metabolized in the liver Because of rapid drug equilibration between the blood and tissue, drug elimination occurs as if the dose is all dissolved in a tank of uniform fluid (a single compartment) from which the drug is eliminated. 10

Volume of Distribution The volume in which the drug is distributed is termed the apparent volume of distribution, V D. The V D is determined from the preinjected amount of the dose in the syringe and the plasma drug concentration resulting immediately after the dose is injected 11

Volume of distribution (V D ) Apparent V D The volume that must be considered in estimating the amount of drug in the body from concentration of the drug found in the sampling compartment. No true physiologic meaning. 12

Volume of Distribution & Elimination Rate constant The apparent volume of distribution is a parameter of the one- compartment model It governs the plasma concentration of the drug after a given dose. Elimination rate constant, k, governs the rate at which the drug concentration in the body declines over time 13

Tissue drug concentration The one- compartment open model does not predict actual drug levels in the tissues. The model assumes that changes in the plasma levels of a drug will result in proportional changes in tissue drug levels The drug in the body, D B, cannot be measured directly, accessible body fluids (such as blood) can be sampled to determine drug concentrations 14

Elimination rate constant (k ) rate of elimination for most drugs from a tissue or from the body is a first- order process the rate of elimination is dependent on the amount or concentration of drug present. Elimination rate constant, k, unit is time 1 (e.g., hr 1 or 1/hr). 15

Elimination rate constant (k ) The elimination rate constant represents the sum of each of these processes: k = km + ke k m = first- order rate process of metabolism k e = first- order rate process of excretion There may be several routes of elimination of drug by metabolism or excretion Each one of these processes has its own first- order rate constant 16

Elimination rate constant (k ) Total elimination of the parent drug from this compartment is effected by metabolism (biotransformation) and/or excretion. 17

Equations First- order kinetics D B = drug in the body at time t D 0 = drug in the body at t = 0. log D B is plotted against t for this equation, a straight line is obtained. 18

The amount of the drug in the body is measured from blood samples V D relates the Concentration (C p ) of the drug measured and the amount of the drug given D B 19

Example 1 g of a drug is dissolved in an unknown volume of water. Upon assay, the concentration of this solution is 1 mg/ml. What is the original volume of this solution? 1 g = 1000 mg: Therefore, the original volume was 1000 ml or 1 L. 20

Cont. If, in the above example, the volume of the solution is known to be 1 L, and the concentration of the solution is 1 mg/ml, then, to calculate the total amount of drug present? Therefore, the total amount of drug in the solution is 1000 mg, or 1 g. 21

Volume of Distribution apparent volume of distribution smaller than, or equal to, the body mass. some drugs, it may be several times the body mass. apparent V D is dependent on C p0. 22

Significance of Volume of Distribution apparent V D is a useful parameter in considering the relative amounts of drug in the vascular and in the extravascular tissues. 23

Significance of Volume of Distribution Large apparent V D : drugs are more concentrated in extravascular tissues and less concentrated intravascularly. Small apparent V D : drug is highly bound to plasma proteins or remains in the vascular region, then C p0 will be higher 24

V D of some drugs 25

V D & body weight The apparent V D can be expressed as a simple volume or in terms of percent of body weight. In expressing the apparent V D in terms of percent body weight, 1- L = 1 kg. For example, if the V D is 3500 ml for a subject weighing 70 kg, the V D expressed as percent of body weight is 26

V D & body weight Values bigger than 100 % indicates that the drug may be concentrated in a certain tissue. 27

Clearance Drug clearance Systemic clearance Total body clearance (Cl T ) Measure of elimination of a drug Regardless of the mechanism or the process It considers the body as a drug eliminating system

Clearance in the One- compartment Body: System of organs model Highly perfused (blood, plasma) Elimination is continuous process (metabolism and excretion) Elimination is complex The concept of clearance is used to quantify elimination

Ways of Expression of Elimination A. Amount(weight) / time B. Volume/ time (Clearance) C. Fraction/ time

A. Elimination as Amount /time Units : mg/ min, mg/hr Simple, absolute Convenient for zero- order elimination process As drug is eliminated in constant amounts Not useful for first- order elimination process

B. Elimination as Volume/time Clearance: concept of expression of the rate of removal in terms of volume of drug solution/ time. Drug concentration in the body decline by first- order kinetics Mass of the drug removed over time is not constant Plasma volume is relatively constant under normal conditions

Constant volume of fluid is filtered by the kidneys 120 ml/min Rate of elimination is proportional to the drug concentration based on first order kinetics

Clearance Volume removal of drug It is constant regardless of concentration Cl = K V D

C. Elimination expressed as Fraction Eliminated /time Applicable regardless of using amount or volume Most flexible and convenient Expresses elimination as fractions One tenth of the drug mount One tenth of the volume of drug solution

Elimination expressed as Fraction Eliminated /time PK incorporates this concept of the first- order equation that considers elimination from one compartment model

Half life (t 1/2 ) Period of time required for amount (D) or concentration (Cp)of a drug to decrease by one half. Constant t "/$ = &.()*, 37

Example 1 A 70- kg volunteer is given an intravenous dose of an antibiotic, and serum drug concentrations were determined at 2 hours and 5 hours after administration. The drug concentrations were 1.2 and 0.3 µg/ml, respectively. What is the biologic half- life for this drug, assuming first- order elimination kinetics?

Example 2 A new drug was given in a single intravenous dose of 200 mg to an 80- kg adult male patient. After 6 hours, the plasma drug concentration of drug was 1.5 mg/100 ml of plasma. Assuming that the apparent V D is 10% of body weight, compute the total amount of drug in the body fluids after 6 hours. What is the half- life of this drug?

Example 3 A single IV bolus injection containing 500 mg of cefamandole nafate (Mandol, Lilly) is given to an adult female patient (63 years, 55 kg) for a septicemic infection. The apparent volume of distribution is 0.1 L/kg and the elimination half- life is 0.75 hour. Assuming the drug is eliminated by first- order kinetics and may be described by a one- compartment model, calculate the following:

Cont. a. The C p 0 b. The amount of drug in the body 4 hours after the dose is given c. The time for the drug to decline to 0.5 µg/ml, the minimum inhibitory concentration for streptococci

Parameters used in PK 42

Any Questions 43

Further Readings Shargel, L., S. Wu- Pong and A. B. Yu (2007). Applied biopharmaceutics & pharmacokinetics, McGraw- Hill. Aulton's Pharmaceutics: The Design andmanufacture of Medicines, M.E.Aulton, Churchill Livingstone, 2007. 44

Thank You 45